Quick Overview: One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Keynote & Fireside Chat with Vas Narasimhan, Vas Narasimhan never planned on becoming a

Novartis Ceo Discusses Developing A - Detailed Overview & Context

One of the top topics at the World Economic Forum is generative AI, with endless discussions on how it can impact a broad range ... Keynote & Fireside Chat with Vas Narasimhan, Vas Narasimhan never planned on becoming a The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data ... "From a pricing standpoint, we have to price our medicines in a way that's reflective of the value they create. And we have to be ... Jan.23 -- Vas Narasimhan, chief executive officer at

Photo Gallery

Novartis CEO discusses developing a new Covid-19 treatment
Novartis CEO discusses how AI will impact drug development
Novartis CEO on the Future of Medicine | a16z Full Interview
Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19
Own the Role You Have (Stop Thinking About the Next) | Novartis CEO Vas Narasimhan
Novartis CEO Vas Narasimhan on The David Rubenstein Show
Novartis CEO Vas Narasimhan: ‘We really should be talking about out-of-pocket costs’ in the U.S.
Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment
Novartis CEO on the company's pledge to provide no-profit medicines to low-income countries
Novartis CEO: Confident we are shielded from any further U.S. tariffs
Novartis CEO Vasant Narasimhan on building trust with society
Novartis CEO: We're never done with M&A
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored